63.49 USD
↗ 0.13 (0.21%)AT CLOSE (03:59 PM EST)
Shares of PTC Therapeutics, Inc. (PTCT) are trading at $63.49. Both sides of the analysis point lower: technicals flash "Sell" and fundamentals confirm with a "Sell" reading. Key drivers include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (55.4%), a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. PTCT is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Nov 13, 2026.